Category: Biotech

Custom Lucite tombstone commemorating equity financing for Georgetown, Texas-based biotech firm DisperSol Technologies.

Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.

Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.

Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.

Custom crystal deal toy commemorating a follow-on offering by EnteroMedics. Ladenburg Thalmann acted as sole bookrunning manager for the follow-on issue by the medical device developer. Based in St. Paul, Minnesota, the company was renamed ReShape Lifesciences in October 2017.

Crystal deal toy marking a follow-on offering by InVivo Therapeutics. Headquartered in Cambridge, Massachusetts, the biotech firm specializes in the treatment of spinal cord injuries. Ladenburg Thalmann acted as sole bookrunner manager on the offering.

Crystal tombstone marking the completion of Series E financing for  Epic Sciences. Funding for the San Diego-based biotech and diagnostics firm was led by Blue Ox Healthcare Partners, a private equity firm based in New York.

Plasma-themed crystal deal toy marking two transactions involving German blood plasma firm Biotest.

Crystal deal toy marking a follow-on stock offering by Cellectar Biosciences. Based in Madison, Wisconsin, the firm develops cancer drugs and imaging tools.